1. Home
  2. QSI vs PCRX Comparison

QSI vs PCRX Comparison

Compare QSI & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum-Si Incorporated

QSI

Quantum-Si Incorporated

N/A

Current Price

$1.28

Market Cap

273.7M

Sector

Health Care

ML Signal

N/A

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

N/A

Current Price

$25.98

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QSI
PCRX
Founded
2013
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.7M
1.0B
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
QSI
PCRX
Price
$1.28
$25.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$2.63
$32.86
AVG Volume (30 Days)
4.2M
892.3K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.47
Revenue
$3,177,000.00
$716,791,000.00
Revenue This Year
N/A
$6.24
Revenue Next Year
$159.68
$9.53
P/E Ratio
N/A
$54.61
Revenue Growth
40.20
3.14
52 Week Low
$0.95
$18.17
52 Week High
$5.77
$27.64

Technical Indicators

Market Signals
Indicator
QSI
PCRX
Relative Strength Index (RSI) 42.85 59.78
Support Level $1.20 $25.48
Resistance Level $1.32 $27.16
Average True Range (ATR) 0.09 1.01
MACD 0.01 0.00
Stochastic Oscillator 27.78 66.13

Price Performance

Historical Comparison
QSI
PCRX

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: